Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Readers on

mendeley: 144 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

SURVIVIN-TARGETING ANTI-TUMOR AGENTS AND USES THEREOF

Application US-20210299123-A1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.